90 related articles for article (PubMed ID: 2098307)
1. Interferon alpha-2b in the treatment of myelofibrosis.
Furesi L; Laghi Pasini F; Forconi S
Haematologica; 1990; 75(6):587-9. PubMed ID: 2098307
[No Abstract] [Full Text] [Related]
2. [System mastocytosis: presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b].
de las Nieves M; Poveda F; Queipo de Llano MP; González-Hermoso C
Sangre (Barc); 1997 Oct; 42(5):430-1. PubMed ID: 9424749
[No Abstract] [Full Text] [Related]
3. [Cytoreductive effect of recombinant alfa-interferon in patients with myelofibrosis with myeloid metaplasia].
Barosi G; Liberato NL; Costa A; Ascari E
Haematologica; 1990; 75 Suppl 4():48-50. PubMed ID: 2074054
[No Abstract] [Full Text] [Related]
4. [Alpha interferon treatment of idiopathic myelofibrosis].
Cervantes F; Alcorta I; Escoda L; Montserrat E; Rozman C
Med Clin (Barc); 1993 Oct; 101(13):498-500. PubMed ID: 8231385
[TBL] [Abstract][Full Text] [Related]
5. A case of interstitial pneumonitis associated with natural alpha-interferon therapy for myelofibrosis.
Nakamura F; Andoh A; Minamiguchi H; Hodohara K; Fujiyama Y; Bamba T
Acta Haematol; 1997; 97(4):222-4. PubMed ID: 9158665
[TBL] [Abstract][Full Text] [Related]
6. Acute myelofibrosis: response to recombinant human interferon alpha-2a.
List AF; Kummet TD; Kerr DM
Leuk Res; 1990; 14(4):321-6. PubMed ID: 2332985
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon alpha (rIFN alpha-2b) may retard progression of early primary myelofibrosis.
Silver RT; Vandris K
Leukemia; 2009 Jul; 23(7):1366-9. PubMed ID: 19440212
[No Abstract] [Full Text] [Related]
8. Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation.
Dagorne A; Douet-Guilbert N; Quintin-Roue I; Guillerm G; Couturier MA; Berthou C; Ianotto JC
Ann Hematol; 2013 Mar; 92(3):407-9. PubMed ID: 22941306
[No Abstract] [Full Text] [Related]
9. Ocular surface squamous neoplasia treated with topical interferon α 2b.
Pujari A
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28100578
[No Abstract] [Full Text] [Related]
10. Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.
Barosi G; Liberato LN; Costa A; Ascari E
Blut; 1989 Jun; 58(6):271-4. PubMed ID: 2736307
[TBL] [Abstract][Full Text] [Related]
11. [Alpha interferon treatment of chronic myeloproliferative disease associated thrombocytosis].
Remes K; Pelliniemi TT
Duodecim; 1993; 109(11):983-9. PubMed ID: 8062671
[No Abstract] [Full Text] [Related]
12. Use of Mesterolone, a non-alkylated anabolic steroid, in myelofibrosis.
Sadullah S; Kruger A; Clarke N; Bell A
Clin Lab Haematol; 1992; 14(4):335-6. PubMed ID: 1478014
[No Abstract] [Full Text] [Related]
13. Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders.
Bonaccorso R; Teresi M; Gebbia V; Tambone Reyes M; Tinnirello D; Di Marco P; Citarrella P; Mansueto S
J Chemother; 1989 Jul; 1(4 Suppl):1266-8. PubMed ID: 16312860
[No Abstract] [Full Text] [Related]
14. Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation.
Sgarabotto D; Zerbinati P; Vianello F; Valeri P; Girolami A; Dazzi F
Haematologica; 1992; 77(4):367-8. PubMed ID: 1427450
[No Abstract] [Full Text] [Related]
15. Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy.
Palumbo AP; Garino AL; Frieri R; Gallone G; Boccadoro M; Pileri A
Haematologica; 1990; 75(6):576-8. PubMed ID: 2098302
[TBL] [Abstract][Full Text] [Related]
16. Is interferon-a an active agent in Castleman's disease?
Pavlidis NA; Briassoulis E; Klouvas G; Bai M
Ann Oncol; 1992 Jan; 3(1):85-6. PubMed ID: 1606076
[No Abstract] [Full Text] [Related]
17. [Interferon and vinblastine in advanced renal carcinoma].
Vicini D; Franceschetti GP; Mirando P; Ruggieri M; Cardellini P
Arch Ital Urol Androl; 1993 Apr; 65(2):181-4. PubMed ID: 8330065
[TBL] [Abstract][Full Text] [Related]
18. Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.
Riley CH; Hansen M; Brimnes MK; Hasselbalch HC; Bjerrum OW; Straten PT; Svane IM; Jensen MK
Eur J Haematol; 2015 Mar; 94(3):227-34. PubMed ID: 25082025
[TBL] [Abstract][Full Text] [Related]
19. Alpha interferon in primary myelofibrosis.
Turri D; Mitra ME; Di Trapani R; Cajozzo A
Haematologica; 1989; 74(4):417-8. PubMed ID: 2507422
[No Abstract] [Full Text] [Related]
20. Alpha interferon as first line therapy for angioimmunoblastic lymphoadenopathy. Possible value of DR+ cells in monitoring therapeutical response.
Milone G; Guglielmo P; Cacciola E; Calogero D; Giustolisi R
Haematologica; 1992; 77(6):524-5. PubMed ID: 1289192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
